Home » Thought Leadership

Thought Leadership

Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 7 posts
August 5, 2020 | Blog

Misconceptions of the 340B Drug Discount Program

Since its inception over 30 years ago, the 340B drug pricing program policy has evolved allowing for unprecedented expansion and influence. With this it has also become highly contested, especially in recent years as more legislation has been put forward to close 340B loopholes.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
June 5, 2019 | Videos

What is the likelihood of increased site-of-care restrictions among US payers?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers what is the likelihood of increased site-of-care-restrictions is among them.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
May 28, 2019 | Videos

Which disease states are on US payers’ radar?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers which disease states are currently on their radar.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
May 20, 2019 | Videos

Will innovative contracts gain momentum in the future?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers whether they think that innovative contracts will gain momentum in the future.